METHOD FOR THE TREATMENT OF ACUTE OPTIC NEUROPATHY IN DRUSEN OF THE OPTIC NERVE HEAD Russian patent published in 2023 - IPC A61F9/07 A61N1/30 A61N2/12 A61K31/44 A61K31/573 A61K31/4425 A61K35/30 A61P27/02 

FIELD: medicine.

SUBSTANCE: invention relates to ophthalmology, and can be used for the treatment of acute optic neuropathy in drusen of the optic nerve head (OND). Dexamethasone 0.5% 0.4 ml is administered parabulbarly, Mexidol 4.0 ml and Cerebrolysin 2 ml are administered intravenously, Actovegin 2 ml is administered intramuscularly once daily for 10 days. From the first day of treatment, 10 electrophoresis sessions are performed through closed eyelids with emoxipin for 5 minutes, once daily. Also, 10 sessions of magnetic therapy are carried out on closed eyelids and temporal region, with an intermittent exposure mode, with an induction of 6 mT, a frequency of 12 Hz for 20 minutes.

EFFECT: invention provides improvement of visual functions in this category of patients due to complex therapy with low pharmacological load on the body, and absence of complications from the central nervous system.

1 cl, 2 ex